absence relationship reported local control hodgkins disease NUMBER NUMBER gy delivered mantle field definitive irradiation dose ranges determined central ray using irregular field calculations benefit dosimetric correction lung inhomogeneity detailed analysis performed dose delivered hilar mediastinal regions mantle field irradiation incorporating lung inhomogeneity corrections indicated dose ranges using 60co NUMBER mv linear accelerator inclusion lung inhomogeneity li corrections revealed dose heterogeneity treatment volume delivering higher total doses hilar lateral mediastinal regions prescribed dose NUMBER gy midline NUMBER mv photons hila mediastinum receive NUMBER gy li corrections similar increases observed 60co mantle field calculations performed ct planning including lung inhomogeneity corrections account anatomic irregularity mediastinal contour interposed lung lung inhomogeneity dosimetric data available conclusions drawn clinical experience based location extent mediastinal disease involvement implications treatment associated late toxicity using histogram analysis considered dose response evaluated dose volume